Cisplatin is a commonly used chemotherapeutic agent in the treatment of different types of malignant
tumors, but nephrotoxicity limits its usage. Therefore, in this study, we aimed to determine the possible protective effect of
Huaiqihuang (HQH) extractum, a kind of Chinese herbal complex that consists of Trametes robiniophila Murr., Lycium barbarum and Polygonatum sibiricum, against nephrotoxicity induced by
cisplatin in mice. We found that pretreatment with HQH significantly attenuated the
cisplatin-induced increase in blood
urea nitrogen (BUN), interstitial congestion, acute renal tubular injury and tubular cell apoptosis and necroptosis. It was further shown that HQH administration reduced
cisplatin-induced release and nuclear-cytoplasmic translocation of
HMGB1 and inactivated its downstream signaling molecules, TLR4 and NFκB, in renal tubular cells; as a result, HQH repressed
cisplatin-induced TNF-α production. As
dexamethasone (Dex) exerts renoprotective effects in severe
Acute kidney injury (AKI), we compared it with HQH and found that HQH showed similar renoprotective effects to
dexamethasone via similar mechanisms. Considering the potential side effects of
corticosteroids, reducing the effectiveness of treatment and shortening survival in solid
tumor patients, we suggest administration of HQH as a potential adjuvant for
cisplatin therapy in solid
tumor patients to preserve renal function.